Vault-13

Nextech Invest Ltd.

Zurich, V8 · CIK 1911010 · 13F filing filed 2022-08-01

Exempt reporting adviser since 2022 · other (specify)

As an employer

$296.5m reported value -15.4% vs Q1 2022
14positions
93.4%in top 10
0 new 1 added 0 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 3,939,529 $76.8m25.90% 25.90% UnchangedShares held: Q3 2021 —, Q4 2021 3.0m, Q1 2022 3.9m, Q2 2022 3.9m
2 EQRX INC COM COM 13,104,424 $61.5m20.73% 20.73% UnchangedShares held: Q3 2021 —, Q4 2021 13.1m, Q1 2022 13.1m, Q2 2022 13.1m
3 KINNATE BIOPHARMA INC COM KNTE KNTE 3,008,243 $37.9m12.80% 12.80% UnchangedShares held: Q3 2021 —, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m
4 PMV PHARMACEUTICALS INC COM PMVP PMVP 1,385,807 $19.7m6.66% 6.66% UnchangedShares held: Q3 2021 —, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m
5 TYRA BIOSCIENCES INC COM TYRA TYRA 2,518,582 $18.0m6.07% 6.07% UnchangedShares held: Q3 2021 —, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
6 MIRATI THERAPEUTICS INC COM MRTX MRTX 263,914 $17.7m5.98% 5.98% AddedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 173.3k, Q2 2022 263.9k +90.6k +90,614 52.3%
7 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,221,145 $15.7m5.28% 5.28% UnchangedShares held: Q3 2021 —, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
8 ARVINAS INC COM ARVN ARVN 287,251 $12.1m4.08% 4.08% UnchangedShares held: Q3 2021 —, Q4 2021 287.3k, Q1 2022 287.3k, Q2 2022 287.3k
9 BLUEPRINT MEDICINES CORP COM BPMC BPMC 188,228 $9.5m3.21% 3.21% UnchangedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 188.2k, Q2 2022 188.2k
10 ARS PHARMACEUTICALS INC COM SPRY SPRY 1,910,029 $8.1m2.73% 2.73% UnchangedShares held: Q3 2021 —, Q4 2021 1.9m, Q1 2022 1.9m, Q2 2022 1.9m
11 RELAY THERAPEUTICS INC COM RLAY RLAY 475,485 $8.0m2.69% 2.69% UnchangedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 475.5k, Q2 2022 475.5k
12 KRONOS BIO INC COM KRON KRON 1,451,537 $5.3m1.78% 1.78% UnchangedShares held: Q3 2021 —, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
13 THESEUS PHARMACEUTICALS INC COM COM 611,310 $3.4m1.14% 1.14% UnchangedShares held: Q3 2021 —, Q4 2021 611.3k, Q1 2022 611.3k, Q2 2022 611.3k
14 C4 THERAPEUTICS INC COM STK CCCC CCCC 375,857 $2.8m0.96% 0.96% UnchangedShares held: Q3 2021 —, Q4 2021 375.9k, Q1 2022 375.9k, Q2 2022 375.9k